Syndeio debuts with $90M+ to bring together synapse repair drugs
An Indianapolis-headquartered biotech reentered the neuroscience scene with more than $90 million in funding on Tuesday morning, rolling up assets from Gate Neurosciences and Boost Neuroscience, with more deals to come. The new company is ...
An Indianapolis-headquartered biotech reentered the neuroscience scene with more than $90 million in funding on Tuesday morning, rolling up assets from Gate Neurosciences and Boost Neuroscience, with more deals to come.
The new company is ...
